floatz

What is floatz?

floatz AI for Drug Discovery helps surface high-potential drug targets grounded in human genetics, expression patterns, and biological pathways, built for translational success. It integrates human genetics, tissue expression, and pathway analysis to map billions of concepts and identify targets with real translational potential, delivering 3 clinically-relevant targets in 14 days.

How to use floatz?

Users define their strategic focus (therapeutic area, indication, constraints). floatz then analyzes the opportunity space by combining literature, disease biology, omics data, pathway networks, and competitive intelligence. Finally, floatz curates and shortlists three high-potential targets, providing scientific rationale, referenced data, and expert review in a decision-ready PDF brief within 14 days.

floatz’s Core Features

AI-driven drug target identification Integration of human genetics, tissue expression, and pathway analysis Delivery of 3 clinically-relevant targets in 14 days Multi-layered analysis (literature, omics, disease biology, competitive intelligence) Expert-reviewed target selection

floatz’s Use Cases

• Identifying novel drug targets for specific disease areas
• Expanding existing drug programs or exploring new therapeutic spaces
• Informing strategic decision-making or licensing evaluation for drug development